Evidence map›Paper›PMID 37601560›Full record

ArticleInfection and drug resistance2023

Carbapenem-Resistant

Guilherme José da Nóbrega Danda, Andreia Craveiro Franco, Elisangela Ana Paula Gomes, Vinícius Vianna Abreu Montanaro, Bernardo José Alves Ferreira Martins, Vitor Viana Bonan de Aguiar

Open access · goldAbstract readCase Reports
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Guilherme José da Nóbrega DandaDepartment of Internal Medicine, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.ORCID 0000-0003-0566-954X
Andreia Craveiro FrancoDepartment of Internal Medicine, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.
Elisangela Ana Paula GomesDepartment of Microbiology, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.ORCID 0000-0002-7738-3105
Vinícius Vianna Abreu MontanaroDepartment of Neurology, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.ORCID 0000-0001-7819-5563
Bernardo José Alves Ferreira MartinsDepartment of Radiology, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.
Vitor Viana Bonan de AguiarDepartment of Neurosurgery, SARAH Network of Rehabilitation Hospitals, Brasília, Federal District, Brazil.
Sarah Network of Rehabilitation Hospitals · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyogenic spondylodiscitis (PS) is a highly morbid and potentially fatal bacterial infection with an increasing incidence in recent decades. Its diagnosis and treatment are challenging, especially with the expansion of multidrug- or extensively drug-resistant bacteria. We report a rare case of PS caused by carbapenem-resistant

Indexed as

antibioticbone and joint infectionresistancevertebral osteomyelitisβ-lactam/β-lactamase inhibitor

Identifiers

PMID37601560
PMCPMC10438467
OpenAlexW4385813342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.